No Data
No Data
HK stocks are fluctuating | The whole minimally invasive surgery sector is trending downward. Shanghai MicroPort Endovascular Medtech (Group) Co., Ltd. is questioned by regulators for its high stock price in the acquisition of OMD. Nomura had pointed out
Today, Microport's entire line has fallen. As of press time, Microport Robot-B (02252) fell by 5.92%, reporting HKD 7.63; Microport Medical (00853) fell by 4.2%, reporting HKD 5.25; Microport Neurotech (02172) fell by 2.72%, reporting HKD 7.15.
China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products
The 90th China International Medical Equipment Fair (CMEF) is set to take place in Shenzhen from October 12th to 15th, 2024. With an expected attendance of over 200,000 visitors from more than 150 countries, the exhibition is poised to be a global showcase of cutting-edge technology.
Sinolink Securities: The pharmaceutical sector is expected to see an improvement in market conditions in the third quarter, and overall growth expectations for the second half of the year are optimistic.
Sinolink Securities released a research report stating that considering the improvement in the medical insurance settlement cycle, the expectation of policy improvement, and the recovery performance of the industry, as well as the fact that institutional medicine hold positions are at a low level, the medical sector will usher in an improved market situation in Q3.
Hong Kong stocks surge | Minimally Invasive Brain Science (02172) up more than 12% again after announcing profit growth, expected to increase revenue by over 30% in the first half of the year.
Minimally invasive Neurosurgery (02172) rose more than 12%, as of press time, it rose 8.09%, to HKD 6.95, with a turnover of HKD 12.001 million.
MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue
MicroPort Scientific (HKG:0853) forecasts a "significant" decline in its net loss for the six months ended June 30 due to a 17% rise in revenue, according to a Monday filing with the Hong Kong Stock
Stock Market News: Minimally Invasive Neurosurgery (02172) fell more than 5% after previously announcing a profit increase of over 30% for the first half of the year.
According to Zhicheng Financial, MicroPort NeuroTech (02172) fell more than 5% and as of the time of release, fell 3.58% to HKD 6.74, with a turnover of HKD 45.532 million. In terms of news, MicroPort NeuroTech announced that it is expected to have a revenue of approximately RMB 0.4 billion to RMB 0.41 billion for the six months ending June, a year-on-year increase of about 34% to 37%. The expected increase in revenue is mainly attributed to breakthrough progress in overseas business, with expected year-on-year revenue growth of approximately 70% to 90% during the reporting period; and the continuous increase in market share of intracranial atherosclerosis stenosis products, leading to significant revenue growth. It is worth noting.
No Data